title: Do recombinant-engineered nanoparticle vaccines hold promise for the prevention of respiratory syncytial virus?
authors.affiliation: Institute of Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA.
authors.forename: Young-Tae
authors.initials: YT
authors.lastname: Lee
authors.affiliation: Institute of Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA.
authors.forename: Young-Man
authors.initials: YM
authors.lastname: Kwon
authors.affiliation: Institute of Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA.
authors.forename: Sang-Moo
authors.initials: SM
authors.lastname: Kang
mesh_terms: D006801:Humans; D053758:Nanoparticles / Q000627:therapeutic use*; D018357:Respiratory Syncytial Virus Infections / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D012136:Respiratory Syncytial Viruses / Q000276:immunology* / Q000472:pathogenicity; D014765:Viral Vaccines / Q000276:immunology / Q000627:therapeutic use*
chemical_list: D014765:Viral Vaccines
keywords: RSV; recombinant nanoparticles; vaccines